Alberta Investment Management Corp (AIMCo)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-144,170
Closed -$1.79M 999
2016
Q4
$1.79M Sell
144,170
-32,310
-18% -$389K 0.02% 476
2016
Q3
$2.42M Sell
176,480
-116,800
-40% -$1.17M 0.02% 407
2016
Q2
$2.17M Sell
293,280
-35,340
-11% -$265K 0.02% 408
2016
Q1
$2.1M Sell
328,620
-1,090,246
-77% -$6.11M 0.03% 377
2015
Q4
$8.87M Buy
1,418,866
+164,580
+13% +$1.08M 0.1% 239
2015
Q3
$7.33M Hold
1,254,286
0.09% 273
2015
Q2
$10.4M Sell
1,254,286
-176,544
-12% -$1.56M 0.11% 234
2015
Q1
$11.8M Buy
1,430,830
+51,470
+4% +$381K 0.12% 223
2014
Q4
$9.48M Buy
+1,379,360
New +$8.63M 0.1% 262

Other funds holding ARIA

Alberta Investment Management Corp (AIMCo)'s ARIA Position: Q1 2017 in Review

Alberta Investment Management Corp (AIMCo) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 144,170 shares — an estimated $1.79M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ARIA in Q4 2014 and held it in 9 quarters. The position peaked at $11.8M in Q1 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 144,170 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.79M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 9 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Ariad Pharmaceuticals Inc position peaked at $11.8M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2017, filed 15 May 2017.